These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2441405

  • 1. Effect of aprotinin and C1-esterase inhibitor on activation of the plasma kallikrein-kinin system in vivo.
    Hoffmann H, Siebeck M, Thetter O, Fink E, Philapitsch A.
    Prog Clin Biol Res; 1987; 236A():159-64. PubMed ID: 2441405
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the kinin-induced pathomechanisms in the development of ARDS by kallikrein inhibition in vivo.
    Thetter O, Hoffmann H, Siebeck M, Welter HF, Fritz H.
    Prog Clin Biol Res; 1987; 236A():127-31. PubMed ID: 2441403
    [Abstract] [Full Text] [Related]

  • 3. Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors.
    Siebeck M, Cheronis JC, Fink E, Kohl J, Spies B, Spannagl M, Jochum M, Fritz H.
    J Appl Physiol (1985); 1994 Dec; 77(6):2675-80. PubMed ID: 7534754
    [Abstract] [Full Text] [Related]

  • 4. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M, Longo J, Kaplan AP.
    J Biol Chem; 1986 Nov 15; 261(32):14965-8. PubMed ID: 3639874
    [Abstract] [Full Text] [Related]

  • 5. Kinin and myocardial infarction: effect of Trasylol on the plasma prekallikrein and kallikrein inhibitor.
    Del Bianco PL, Franchi G, Lombardi M, Caleri D, Curradi C, Sicuteri F.
    Adv Biosci; 1978 Jul 22; 17():187-95. PubMed ID: 314912
    [No Abstract] [Full Text] [Related]

  • 6. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO, Erichsen NS, Gallimore MJ, Amundsen E.
    Adv Shock Res; 1980 Jul 22; 4():1-10. PubMed ID: 6172027
    [Abstract] [Full Text] [Related]

  • 7. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ, Lee SK.
    Pediatr Res; 1975 Sep 22; 9(9):705-9. PubMed ID: 53808
    [Abstract] [Full Text] [Related]

  • 8. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever.
    Yamada T, Harber P, Pettit GW, Wing DA, Oster CN.
    Ann Intern Med; 1978 Jun 22; 88(6):764-8. PubMed ID: 307354
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock.
    Siebeck M, Fink E, Weipert J, Jochum M, Fritz H, Spannagl M, Kroworsch P, Shimamoto K, Schweiberer L.
    J Trauma; 1993 Feb 22; 34(2):193-8. PubMed ID: 7681484
    [Abstract] [Full Text] [Related]

  • 10. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F, Keus JF, Koedam JA, Rietveld A, Bouma BN.
    Adv Exp Med Biol; 1983 Feb 22; 156():143-8. PubMed ID: 6190365
    [No Abstract] [Full Text] [Related]

  • 11. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW, Edelman R, Scott CF, Gilman RH.
    J Clin Invest; 1978 Feb 22; 61(2):287-96. PubMed ID: 74379
    [Abstract] [Full Text] [Related]

  • 12. Prekallikrein activation in the adult respiratory distress syndrome.
    Schapira M, Gardaz JP, Py P, Lew PD, Perrin LH, Suter PM.
    Bull Eur Physiopathol Respir; 1985 Feb 22; 21(3):237-41. PubMed ID: 3873975
    [Abstract] [Full Text] [Related]

  • 13. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT, Kucich U, Hack CE, Gluszko P, Niewiarowski S, Colman RW, Edmunds LH.
    J Thorac Cardiovasc Surg; 1993 Jul 22; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M, Scott CF, Colman RW.
    Biochemistry; 1981 May 12; 20(10):2738-43. PubMed ID: 6910423
    [Abstract] [Full Text] [Related]

  • 16. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats.
    Katori M, Majima M, Mohsin SS, Hanazuka M, Mizogami S, Oh-ishi S.
    Agents Actions Suppl; 1992 May 12; 38 ( Pt 3)():235-42. PubMed ID: 1281379
    [Abstract] [Full Text] [Related]

  • 17. [Hepatic protein synthesis of the kallikrein-kininogen-kinin system].
    Adam A, Reynaert M, Damas P, Ers P, Boulanger J, Roeseler J, Faymonville ME, Lamy M, Damas J.
    Presse Med; 1988 Feb 06; 17(4):151-4. PubMed ID: 2964610
    [Abstract] [Full Text] [Related]

  • 18. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system.
    Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T, Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin SS.
    Hypertension; 1991 Jun 06; 17(6 Pt 1):806-13. PubMed ID: 1710605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
    Waeber G, Schapira M, Waeber B, Aubert JF, Nussberger J, Brunner HR.
    Circ Shock; 1988 Dec 06; 26(4):375-82. PubMed ID: 2463882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.